Gardner Lewis Asset Management’s Syneron Medical Ltd ELOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
– Sell
-51,703
Closed -$569K – 126
2017
Q3
$569K Sell
51,703
-1,586,096
-97% -$17.4M 0.04% 98
2017
Q2
$17.9M Buy
+1,637,799
New +$18M 1.19% 20

Gardner Lewis Asset Management's ELOS Position: Q4 2017 in Review

Gardner Lewis Asset Management sold out of Syneron Medical Ltd (ELOS) in Q4 2017, closing a stake of 51,703 shares — an estimated $569K sold.

Gardner Lewis Asset Management first reported a position in ELOS in Q2 2017 and held it in 2 quarters. The position peaked at $17.9M in Q2 2017. 1 fund tracked by Wall St. Rank holds ELOS as of Q4 2017.

  • Gardner Lewis Asset Management reported no remaining Syneron Medical Ltd position as of Q4 2017 after selling out during the quarter.
  • Gardner Lewis Asset Management sold 51,703 Syneron Medical Ltd shares in Q4 2017, an estimated $569K.
  • Gardner Lewis Asset Management first reported a position in Syneron Medical Ltd in Q2 2017 and held it in 2 quarters.
  • Gardner Lewis Asset Management's Syneron Medical Ltd position peaked at $17.9M in Q2 2017.
  • 1 fund tracked by Wall St. Rank held Syneron Medical Ltd as of Q4 2017.

Based on Gardner Lewis Asset Management's 13F filing for Q4 2017, filed 14 Feb 2018.